Catalyst
Slingshot members are tracking this event:
Updated data from Incyte's (INCY) Phase 1/2 ECHO-202/KEYNOTE-037 study in treating cancer with epacadostat in combination with KEYTRUDA, will be highlighted in an oral presentation on Saturday, 9 Sept 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| INCY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 09, 2017
Occurred Source:
http://www.incyte.com/media/recent-news.aspx
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Echo-20, Keynote-037, Phase 1/2 Study
